Cargando…

Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil

BACKGROUND: The body composition of patients has been associated with tolerability and effectiveness of anticancer therapy. This study aimed to assess the influence of the skeletal muscle index (SMI) on the pharmacokinetics and toxicity of fluorouracil. METHODS: Patients treated in an oncological pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmulenson, Eduard, Zimmermann, Nigina, Müller, Lothar, Kapsa, Stefanie, Sihinevich, Iryna, Jaehde, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939223/ https://www.ncbi.nlm.nih.gov/pubmed/35941837 http://dx.doi.org/10.1002/cam4.5118

Ejemplares similares

Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach
por: Schmulenson, Eduard, et al.
Publicado: (2020)

Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol
por: Mc Laughlin, Anna M., et al.
Publicado: (2021)

Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic–pharmacodynamic model in gastrointestinal cancer patients
por: Arshad, Usman, et al.
Publicado: (2020)

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
por: Schlender, Jan-Frederik, et al.
Publicado: (2016)

The Acute Effects of 5 Fluorouracil on Skeletal Muscle Resident and Infiltrating Immune Cells in Mice
por: VanderVeen, Brandon N., et al.
Publicado: (2020)

Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia
por: Campelj, Dean G., et al.
Publicado: (2021)

Abdominal irradiation modulates 5-Fluorouracil pharmacokinetics
por: Hsieh, Chen-Hsi, et al.
Publicado: (2010)

A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
por: Schlender, Jan-Frederik, et al.
Publicado: (2018)

Applications of Physiologically Based Pharmacokinetic Modeling of Rivaroxaban—Renal and Hepatic Impairment and Drug‐Drug Interaction Potential
por: Willmann, Stefan, et al.
Publicado: (2021)

Local Irradiation Modulates the Pharmacokinetics of Metabolites in 5-Fluorouracil—Radiotherapy–Pharmacokinetics Phenomenon
por: Liu, Ju-Han, et al.
Publicado: (2020)

Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia
por: Pigneur, Frédéric, et al.
Publicado: (2023)

Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.
por: McDermott, B. J., et al.
Publicado: (1983)

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
por: Retlich, Silke, et al.
Publicado: (2015)

Fatty Liver Index and Skeletal Muscle Density
por: Pasco, Julie A., et al.
Publicado: (2022)

Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity
por: Milano, G, et al.
Publicado: (1999)

Extreme Energy Events Monitoring report
por: Baimukhamedova, Nigina
Publicado: (2015)

Pharmacokinetic Modulation of Plasma 5‐Fluorouracil Concentrations to Potentiate the Antitumor Activity of Continuous Venous Infusion of 5‐Fluorouracil
por: Fujii, Setsuro, et al.
Publicado: (1989)

Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy
por: Nara, Katsuhiko, et al.
Publicado: (2023)

Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles
por: Li, Su, et al.
Publicado: (2008)

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

Evaluation of an alternative skeletal muscle index for skeletal muscle mass assessment in a group of Australian women
por: Yee, Ming Li, et al.
Publicado: (2022)

New Skeletal Muscle Mass Index in Diagnosis of Sarcopenia
por: Moon, Jeong Jae, et al.
Publicado: (2018)

Encephalopathy, lactic acidosis, hyperammonaemia and 5-fluorouracil toxicity.
por: Valik, D.
Publicado: (1998)

Pharmacokinetic variables of medium molecular weight cross linked chitosan nanoparticles to enhance the bioavailability of 5-fluorouracil and reduce the acute oral toxicity
por: Sethi, Aisha, et al.
Publicado: (2021)

Lack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics.
por: Seymour, M. T., et al.
Publicado: (1994)

Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel
por: Yi, Hee, et al.
Publicado: (2010)

Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study
por: Atefinezhad, Motahare, et al.
Publicado: (2022)

Effects of Cannabidiol Supplementation on Skeletal Muscle Regeneration after Intensive Resistance Training
por: Isenmann, Eduard, et al.
Publicado: (2021)

Influence of the appendicular skeletal muscle mass index on the bone mineral density of postmenopausal women
por: da Cruz, Geise Ferreira, et al.
Publicado: (2021)

The effect of leucovorin on the therapeutic index of fluorouracil in cancer patients.
por: DeLap, R. J.
Publicado: (1988)

The effect of propolis on 5-fluorouracil-induced cardiac toxicity in rats
por: Barary, Mohammad, et al.
Publicado: (2022)

Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans
por: Naren, Gerile, et al.
Publicado: (2022)

Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation
por: Haberecht-Müller, Stefanie, et al.
Publicado: (2021)

The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases.
por: Goldberg, J. A., et al.
Publicado: (1990)

Local pelvic irradiation modulates Pharmacokinetics of 5-Fluorouracil in the plasma but not in the Lymphatic System
por: Hsieh, Chen-Hsi, et al.
Publicado: (2015)

Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma
por: Gao, Jian, et al.
Publicado: (2018)

An Unnecessary Pain: Using Pharmacogenetics for Statin-related Skeletal Muscle Toxicity
por: Alzghari, Saeed K
Publicado: (2018)

Integrated metabolic models for xenobiotic induced mitochondrial toxicity in skeletal muscle
por: Dott, William, et al.
Publicado: (2017)

Influence of some factors on cadmium pharmacokinetics and toxicity
por: Kostial, Krista, et al.
Publicado: (1979)

Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicity
por: Ortland, Imke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4pth68k5r6ma18a1f5d5n9b8uc